Q1 Earnings Estimate for NRIX Issued By Leerink Partnrs
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for shares of Nurix Therapeutics in a research note issued to investors on Monday, March 17th. Leerink Partnrs analyst F. Khurshid forecasts that the company will post earnings per share of ($0.89) for the […]
